Top compounds associated with response to CCDC120


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 GDSC1000 pan-cancer AAC -0.1 0.005
mRNA pluripotin CTRPv2 pan-cancer AAC -0.11 0.005
mRNA lovastatin CTRPv2 pan-cancer AAC -0.12 0.005
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.1 0.006
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.1 0.006
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.21 0.007
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.21 0.007
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.007
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.095 0.007
Download CSV